多组学整合揭示酒精性肝炎葡萄糖利用重编程并鉴定新型己糖激酶
该研究对酒精性肝炎(AH)、酒精性肝硬化患者及正常肝组织进行代谢组与转录组整合分析,发现AH患者糖酵解/糖异生、三羧酸循环等代谢中间物改变,HKDC1为上调最显著的激酶,其高表达与急性肾损伤发生和生存率降低相关,提示HKDC1是AH的潜在生物标志物和治疗靶点。
要点
- AH患者肝脏存在葡萄糖代谢广泛重编程,涉及糖酵解/糖异生及三羧酸循环中间物改变。
- HKDC1是AH中上调最显著的葡萄糖代谢激酶,其启动子/增强子区组蛋白活性标记增加。
- 高HKDC1水平与急性肾损伤发生和生存率降低相关。
核心结论
- AH存在广泛的葡萄糖代谢重编程,HKDC1上调可能参与代谢失调并作为新型生物标志物和治疗靶点。
研究设计与样本
- 对AH、酒精性肝硬化患者及肝切除正常肝组织进行代谢组和转录组整合分析,并行染色质免疫沉淀测序及原代大鼠/人肝细胞和HepG2细胞功能研究。
主要发现
- AH患者糖酵解/糖异生、三羧酸循环及单糖/双糖代谢中间物水平发生特异性改变。
- 转录组与代谢组整合分析显示AH患者使用替代能量途径、代谢物汇和瓶颈及糖储存失调。
- HKDC1是AH中上调最显著的激酶,其基因组区域活性启动子和增强子标记增加。
- 高HKDC1水平与急性肾损伤发生和生存率降低相关。
- 增加HKDC1活性促进原代大鼠肝细胞中葡萄糖-6-磷酸和糖原积累。
临床怎么用
- HKDC1高表达与AH患者急性肾损伤和生存率降低相关,提示其作为预后标志物的潜在价值。
- HKDC1可能成为AH治疗的新靶点,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: We recently showed that alcoholic hepatitis (AH) is characterized by dedifferentiation of hepatocytes and loss of mature functions. Glucose metabolism is tightly regulated in healthy hepatocytes. We hypothesize that AH may lead to metabolic reprogramming of the liver, including dysregulation of glucose metabolism. METHODS: We performed integrated metabolomic and transcriptomic analyses of liver tissue from patients with AH or alcoholic cirrhosis or normal liver tissue from hepatic resection. Focused analyses of chromatin immunoprecipitation coupled to DNA sequencing was performed. Functional in vitro studies were performed in primary rat and human hepatocytes and HepG2 cells. RESULTS: Patients with AH exhibited specific changes in the levels of intermediates of glycolysis/gluconeogenesis, the tricarboxylic acid cycle, and monosaccharide and disaccharide metabolism. Integrated analysis of the transcriptome and metabolome showed the used of alternate energetic pathways, metabolite sinks and bottlenecks, and dysregulated glucose storage in patients with AH. Among genes involved in glucose metabolism, hexokinase domain containing 1 (HKDC1) was identified as the most up-regulated kinase in patients with AH. Histone active promoter and enhancer markers were increased in the HKDC1 genomic region. High HKDC1 levels were associated with the development of acute kidney injury and decreased survival. Increased HKDC1 activity contributed to the accumulation of glucose-6-P and glycogen in primary rat hepatocytes. CONCLUSIONS: Altered metabolite levels and messenger RNA expression of metabolic enzymes suggest the existence of extensive reprogramming of glucose metabolism in AH. Increased HKDC1 expression may contribute to dysregulated glucose metabolism and represents a novel biomarker and therapeutic target for AH.
引用
- Massey V, Parrish A, Argemi J, et al. Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis. Gastroenterology. 2020. PMID: 33309778. doi:10.1053/j.gastro.2020.12.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。